Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study

Predictors of an Invasive Breast Cancer Recurrence after DCIS: A Systematic Review and Meta-analyses

(2019) Lindy L. Visser et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA).

(2019) Chizuko Kanbayashi et al.   JOURNAL OF CLINICAL ONCOLOGY

Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study

(2019) Antonio Ponti et al.   BREAST CANCER RESEARCH AND TREATMENT

Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project

(2018) Alastair M. Thompson et al.   EUROPEAN JOURNAL OF CANCER

Ductal Carcinoma In Situ and Margins

(2017) Audree B. Tadros et al.   ANNALS OF SURGERY

The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis

(2016) M. Luke Marinovich et al.   ANNALS OF SURGICAL ONCOLOGY

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women

(2016) Lotte E. Elshof et al.   BREAST CANCER RESEARCH AND TREATMENT

Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study

(2016) Stephen W Duffy et al.   LANCET ONCOLOGY

The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ

(2015) A. Francis et al.   CLINICAL ONCOLOGY

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study

(2015) Lotte E. Elshof et al.   EUROPEAN JOURNAL OF CANCER

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ

(2015) Steven A. Narod et al.   JAMA Oncology

Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS)

(2014) Shan Cheung et al.   BREAST

Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis

(2013) Eileen Rakovitch et al.   BREAST CANCER RESEARCH AND TREATMENT

Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery

(2013) John R Benson et al.   LANCET ONCOLOGY

Trends in Detection of Invasive Cancer and Ductal Carcinoma In Situ at Biennial Screening Mammography in Spain: A Retrospective Cohort Study

(2013) Marta Román et al.   PLoS One

Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence

(2012) Archie Bleyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

(2011) I. L. Wapnir et al.   JNCI-Journal of the National Cancer Institute

Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes

(2010) B. A. Virnig et al.   JNCI-Journal of the National Cancer Institute

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

(2010) Jack Cuzick et al.   LANCET ONCOLOGY